Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Toll-like receptors (TLRs) are a family of evolutionarily conserved, type I transmembrane proteins that play a central role in the innate immune system. They function as pattern recognition receptors (PRRs), detecting pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs) to initiate immune responses. They are composed of an extracellular LRR domain for ligand recognition, a transmembrane helix, and a cytoplasmic TIR domain for downstream signaling.
TLRs recognize PAMPs and DAMPs, leading to activation of intracellular signaling pathways via adaptor proteins like MyD88 and TRIF, ultimately inducing the expression of genes involved in inflammation and immunity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Toll-like Receptor (TLR).